{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:36:57Z","timestamp":1793036217456,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-020-00161-w","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T17:12:05Z","timestamp":1610557925000},"page":"98-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["FYN\u2013TRAF3IP2 induces NF-\u03baB signaling-driven peripheral T-cell lymphoma"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8717-2435","authenticated-orcid":false,"given":"Christine S.","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Reglero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Aidan","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5414-7900","authenticated-orcid":false,"given":"Wen-Hsuan W.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha J.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Soderquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2554-1498","authenticated-orcid":false,"given":"Claudia","family":"Fi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0864","authenticated-orcid":false,"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-048X","authenticated-orcid":false,"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7946-9255","authenticated-orcid":false,"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-3207","authenticated-orcid":false,"given":"Teresa","family":"Palomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-8574","authenticated-orcid":false,"given":"Adolfo A.","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"161_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose, J., Armitage, J. & Weisenburger, D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26, 4124\u20134130 (2008).","journal-title":"J. Clin. Oncol."},{"key":"161_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25\u201338 (2011).","journal-title":"Cancer Cell"},{"key":"161_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng.2873","volume":"46","author":"T Palomero","year":"2014","unstructured":"Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat. Genet. 46, 166\u2013170 (2014).","journal-title":"Nat. Genet."},{"key":"161_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto, M. et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 171\u2013175 (2014).","journal-title":"Nat. Genet."},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","volume":"119","author":"RA Cairns","year":"2012","unstructured":"Cairns, R. A. et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119, 1901\u20131903 (2012).","journal-title":"Blood"},{"key":"161_CR6","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","volume":"126","author":"C Wang","year":"2015","unstructured":"Wang, C. et al. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood 126, 1741\u20131752 (2015).","journal-title":"Blood"},{"key":"161_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1111708","volume":"366","author":"L Couronne","year":"2012","unstructured":"Couronne, L., Bastard, C. & Bernard, O. A. TET2 and DNMT3A mutations in human T-cell lymphoma. N. Engl. J. Med. 366, 95\u201396 (2012).","journal-title":"N. Engl. J. Med."},{"key":"161_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2916","volume":"46","author":"HY Yoo","year":"2014","unstructured":"Yoo, H. Y. et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 371\u2013375 (2014).","journal-title":"Nat. Genet."},{"key":"161_CR9","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1182\/blood-2014-02-555946","volume":"123","author":"R Manso","year":"2014","unstructured":"Manso, R. et al. The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature. Blood 123, 2893\u20132894 (2014).","journal-title":"Blood"},{"key":"161_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide, O. et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123, 1293\u20131296 (2014).","journal-title":"Blood"},{"key":"161_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1073\/pnas.1608839114","volume":"114","author":"F Abate","year":"2017","unstructured":"Abate, F. et al. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc. Natl Acad. Sci. USA 114, 764\u2013769 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"161_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","volume":"128","author":"RL Boddicker","year":"2016","unstructured":"Boddicker, R. L. et al. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma. Blood 128, 1234\u20131245 (2016).","journal-title":"Blood"},{"key":"161_CR13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2015.357","volume":"30","author":"J Rohr","year":"2016","unstructured":"Rohr, J. et al. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. Leukemia 30, 1062\u20131070 (2016).","journal-title":"Leukemia"},{"key":"161_CR14","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","volume":"128","author":"D Vallois","year":"2016","unstructured":"Vallois, D. et al. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell\u2013derived lymphomas. Blood 128, 1490\u20131502 (2016).","journal-title":"Blood"},{"key":"161_CR15","doi-asserted-by":"crossref","unstructured":"Watatani, Y. et al. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia 33, 2867\u20132883 (2019).","DOI":"10.1038\/s41375-019-0473-1"},{"key":"161_CR16","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","volume":"37","author":"AD Attygalle","year":"2013","unstructured":"Attygalle, A. D., Feldman, A. L. & Dogan, A. ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma. Am. J. Surg. Pathol. 37, 1456\u20131457 (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"161_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","volume":"33","author":"Y Huang","year":"2009","unstructured":"Huang, Y. et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am. J. Surg. Pathol. 33, 682\u2013690 (2009).","journal-title":"Am. J. Surg. Pathol."},{"key":"161_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel, B., Vinatzer, U., Willheim, M., Raderer, M. & Chott, A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 20, 313\u2013318 (2006).","journal-title":"Leukemia"},{"key":"161_CR19","doi-asserted-by":"publisher","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","volume":"23","author":"EH Palacios","year":"2004","unstructured":"Palacios, E. H. & Weiss, A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23, 7990\u20138000 (2004).","journal-title":"Oncogene"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"35603","DOI":"10.1074\/jbc.C600256200","volume":"281","author":"SH Chang","year":"2006","unstructured":"Chang, S. H., Park, H. & Dong, C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281, 35603\u201335607 (2006).","journal-title":"J. Biol. Chem."},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1073\/pnas.160265197","volume":"97","author":"X Li","year":"2000","unstructured":"Li, X. et al. Act1, an NF-\u03baB-activating protein. Proc. Natl Acad. Sci. USA 97, 10489\u201310493 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"161_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1439","volume":"8","author":"Y Qian","year":"2007","unstructured":"Qian, Y. et al. The adaptor Act1 is required for interleukin 17\u2013dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247\u2013256 (2007).","journal-title":"Nat. Immunol."},{"key":"161_CR23","first-page":"556\u2013567","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen, S. L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9, 556\u2013567 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"161_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","volume":"30","author":"H Ishigame","year":"2009","unstructured":"Ishigame, H. et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108\u2013119 (2009).","journal-title":"Immunity"},{"key":"161_CR25","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.4049\/jimmunol.179.8.5462","volume":"179","author":"RE Kuestner","year":"2007","unstructured":"Kuestner, R. E. et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179, 5462\u20135473 (2007).","journal-title":"J. Immunol."},{"key":"161_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ajh.24203","volume":"91","author":"RA Wilcox","year":"2016","unstructured":"Wilcox, R. A. A three-signal model of T-cell lymphoma pathogenesis. Am. J. Hematol. 91, 113\u2013122 (2016).","journal-title":"Am. J. Hematol."},{"key":"161_CR27","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/ni.2940","volume":"15","author":"AK Chakraborty","year":"2014","unstructured":"Chakraborty, A. K. & Weiss, A. Insights into the initiation of TCR signaling. Nat. Immunol. 15, 798\u2013807 (2014).","journal-title":"Nat. Immunol."},{"key":"161_CR28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1242\/jcs.034843","volume":"122","author":"I Sato","year":"2009","unstructured":"Sato, I. et al. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. J. Cell Sci. 122, 965\u2013975 (2009).","journal-title":"J. Cell Sci."},{"key":"161_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1091\/mbc.8.6.1159","volume":"8","author":"A Wolven","year":"1997","unstructured":"Wolven, A., Okamura, H., Rosenblatt, Y. & Resh, M. D. Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol. Biol. Cell 8, 1159\u20131173 (1997).","journal-title":"Mol. Biol. Cell"},{"key":"161_CR30","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1515\/hsz-2016-0216","volume":"397","author":"I Meininger","year":"2016","unstructured":"Meininger, I. & Krappmann, D. Lymphocyte signaling and activation by the CARMA1\u2013BCL10\u2013MALT1 signalosome. Biol. Chem. 397, 1315\u20131333 (2016).","journal-title":"Biol. Chem."},{"key":"161_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ni824","volume":"3","author":"D Wang","year":"2002","unstructured":"Wang, D. et al. A requirement for CARMA1 in TCR-induced NF-\u03baB activation. Nat. Immunol. 3, 830\u2013835 (2002).","journal-title":"Nat. Immunol."},{"key":"161_CR32","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1172\/JCI99436","volume":"128","author":"L Fontan","year":"2018","unstructured":"Fontan, L. et al. Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth. J. Clin. Invest. 128, 4397\u20134412 (2018).","journal-title":"J. Clin. Invest."},{"key":"161_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06573-8","volume":"9","author":"F Schlauderer","year":"2018","unstructured":"Schlauderer, F. et al. Molecular architecture and regulation of BCL10\u2013MALT1 filaments. Nat. Commun. 9, 4041 (2018).","journal-title":"Nat. Commun."},{"key":"161_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imr.12302","volume":"266","author":"MC Walsh","year":"2015","unstructured":"Walsh, M. C., Lee, J. & Choi, Y. Tumor necrosis factor receptor-associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol. Rev. 266, 72\u201392 (2015).","journal-title":"Immunol. Rev."},{"key":"161_CR35","first-page":"ra63","volume":"2","author":"C Liu","year":"2009","unstructured":"Liu, C. et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal. 2, ra63 (2009).","journal-title":"Sci. Signal."},{"key":"161_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00239-011-9450-7","volume":"72","author":"G Ryzhakov","year":"2011","unstructured":"Ryzhakov, G., Blazek, K. & Udalova, I. A. Evolution of vertebrate immunity: sequence and functional analysis of the SEFIR domain family member Act1. J. Mol. Evol. 72, 521\u2013530 (2011).","journal-title":"J. Mol. Evol."},{"key":"161_CR37","doi-asserted-by":"publisher","first-page":"12881","DOI":"10.1074\/jbc.M110.199547","volume":"286","author":"SU Sonder","year":"2011","unstructured":"Sonder, S. U. et al. IL-17-induced NF-\u03baB activation via CIKS\/Act1: physiologic significance and signaling mechanisms. J. Biol. Chem. 286, 12881\u201312890 (2011).","journal-title":"J. Biol. Chem."},{"key":"161_CR38","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","volume":"120","author":"F Lemonnier","year":"2012","unstructured":"Lemonnier, F. et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120, 1466\u20131469 (2012).","journal-title":"Blood"},{"key":"161_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4049\/jimmunol.173.1.68","volume":"173","author":"T Chtanova","year":"2004","unstructured":"Chtanova, T. et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells that provide help for B cells. J. Immunol. 173, 68\u201378 (2004).","journal-title":"J. Immunol."},{"key":"161_CR40","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L de Leval","year":"2007","unstructured":"de Leval, L. et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109, 4952\u20134963 (2007).","journal-title":"Blood"},{"key":"161_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","volume":"128","author":"NS Saba","year":"2016","unstructured":"Saba, N. S. et al. Pathogenic role of B-cell receptor signaling and canonical NF-\u03baB activation in mantle cell lymphoma. Blood 128, 82\u201392 (2016).","journal-title":"Blood"},{"key":"161_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcancer.2018.02.007","volume":"56","author":"N Awasthee","year":"2019","unstructured":"Awasthee, N. et al. Targeting I\u03baB kinases for cancer therapy. Semin. Cancer Biol. 56, 12\u201324 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"161_CR43","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1074\/jbc.M209677200","volume":"278","author":"JR Burke","year":"2003","unstructured":"Burke, J. R. et al. BMS-345541 is a highly selective inhibitor of I\u03baB kinase that binds at an allosteric site of the enzyme and blocks NF-\u03baB-dependent transcription in mice. J. Biol. Chem. 278, 1450\u20131456 (2003).","journal-title":"J. Biol. Chem."},{"key":"161_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bmcl.2005.09.035","volume":"16","author":"R Waelchli","year":"2006","unstructured":"Waelchli, R. et al. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorg. Med. Chem. Lett. 16, 108\u2013112 (2006).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"161_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1600-065X.2012.01105.x","volume":"246","author":"KH Lim","year":"2012","unstructured":"Lim, K. H., Yang, Y. & Staudt, L. M. Pathogenetic importance and therapeutic implications of NF-\u03baB in lymphoid malignancies. Immunol. Rev. 246, 359\u2013378 (2012).","journal-title":"Immunol. Rev."},{"key":"161_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2016.05.002","volume":"39","author":"D Krappmann","year":"2016","unstructured":"Krappmann, D. & Vincendeau, M. Mechanisms of NF-\u03baB deregulation in lymphoid malignancies. Semin. Cancer Biol. 39, 3\u201314 (2016).","journal-title":"Semin. Cancer Biol."},{"key":"161_CR47","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1078-0432.CCR-12-3151","volume":"19","author":"L Odqvist","year":"2013","unstructured":"Odqvist, L. et al. NIK controls classical and alternative NF-\u03baB activation and is necessary for the survival of human T-cell lymphoma cells. Clin. Cancer Res. 19, 2319\u20132330 (2013).","journal-title":"Clin. Cancer Res."},{"key":"161_CR48","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","volume":"19","author":"B Mart\u00ednez-Delgado","year":"2005","unstructured":"Mart\u00ednez-Delgado, B. et al. Differential expression of NF-\u03baB pathway genes among peripheral T-cell lymphomas. Leukemia 19, 2254\u20132263 (2005).","journal-title":"Leukemia"},{"key":"161_CR49","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1053\/hupa.2000.20370","volume":"31","author":"KF Izban","year":"2000","unstructured":"Izban, K. F. et al. Constitutive expression of NF-\u03baB is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Hum. Pathol. 31, 1482\u20131490 (2000).","journal-title":"Hum. Pathol."},{"key":"161_CR50","first-page":"2839","volume":"8","author":"NS Fracchiolla","year":"1993","unstructured":"Fracchiolla, N. S. et al. Structural alterations of the NF-\u03baB transcription factor lyt-10 in lymphoid malignancies. Oncogene 8, 2839\u20132845 (1993).","journal-title":"Oncogene"},{"key":"161_CR51","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0006-291X(03)01474-8","volume":"308","author":"E Derudder","year":"2003","unstructured":"Derudder, E. et al. Identification and characterization of p100HB, a new mutant form of p100\/NF-\u03baB2. Biochem. Biophys. Res. Commun. 308, 744\u2013749 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"161_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ccell.2019.07.008","volume":"36","author":"L Mondragon","year":"2019","unstructured":"Mondragon, L. et al. GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-\u03baB-dependent mechanism. Cancer Cell 36, 268\u2013287 (2019).","journal-title":"Cancer Cell"},{"key":"161_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","volume":"33","author":"JR Cortes","year":"2018","unstructured":"Cortes, J. R. et al. RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis. Cancer Cell 33, 259\u2013273 (2018).","journal-title":"Cancer Cell"},{"key":"161_CR54","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1182\/blood-2017-11-818617","volume":"132","author":"SY Ng","year":"2018","unstructured":"Ng, S. Y. et al. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. Blood 132, 935\u2013947 (2018).","journal-title":"Blood"},{"key":"161_CR55","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-08-3719","volume":"70","author":"C Dierks","year":"2010","unstructured":"Dierks, C. et al. The ITK\u2013SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res. 70, 6193\u20136204 (2010).","journal-title":"Cancer Res."},{"key":"161_CR56","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20092042","volume":"207","author":"K Pechloff","year":"2010","unstructured":"Pechloff, K. et al. The fusion kinase ITK\u2013SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J. Exp. Med. 207, 1031\u20131044 (2010).","journal-title":"J. Exp. Med."},{"key":"161_CR57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1074-7613(03)00237-1","volume":"19","author":"M Schmidt-Supprian","year":"2003","unstructured":"Schmidt-Supprian, M. et al. Mature T cells depend on signaling through the IKK complex. Immunity 19, 377\u2013389 (2003).","journal-title":"Immunity"},{"key":"161_CR58","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1093\/bioinformatics\/btr467","volume":"27","author":"MK Iyer","year":"2011","unstructured":"Iyer, M. K., Chinnaiyan, A. M. & Maher, C. A. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27, 2903\u20132904 (2011).","journal-title":"Bioinformatics"},{"key":"161_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12918-014-0097-z","volume":"8","author":"F Abate","year":"2014","unstructured":"Abate, F. et al. Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer. BMC Syst. Biol. 8, 97 (2014).","journal-title":"BMC Syst. Biol."},{"key":"161_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-6-r84","volume":"15","author":"RM Layer","year":"2014","unstructured":"Layer, R. M., Chiang, C., Quinlan, A. R. & Hall, I. M. LUMPY: a probabilistic framework for structural variant discovery. Genome Biol. 15, R84 (2014).","journal-title":"Genome Biol."},{"key":"161_CR61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2310\/7290.2009.00007","volume":"8","author":"EA Kimbrel","year":"2009","unstructured":"Kimbrel, E. A., Davis, T. N., Bradner, J. E. & Kung, A. L. In vivo pharmacodynamic imaging of proteasome inhibition. Mol. Imaging 8, 140\u2013147 (2009).","journal-title":"Mol. Imaging"},{"key":"161_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","volume":"20","author":"K Moran-Crusio","year":"2011","unstructured":"Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11\u201324 (2011).","journal-title":"Cancer Cell"},{"key":"161_CR63","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/dvg.22052","volume":"50","author":"K Aghajani","year":"2012","unstructured":"Aghajani, K., Keerthivasan, S., Yu, Y. & Gounari, F. Generation of CD4CreERT2 transgenic mice to study development of peripheral CD4-T-cells. Genesis 50, 908\u2013913 (2012).","journal-title":"Genesis"},{"key":"161_CR64","doi-asserted-by":"publisher","first-page":"412\u2013418","DOI":"10.1158\/2326-6066.CIR-15-0240","volume":"4","author":"MS Hsu","year":"2016","unstructured":"Hsu, M. S. et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunol. Res. 4, 412\u2013418 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"161_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"161_CR66","first-page":"15545\u201315550","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00161-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T21:05:20Z","timestamp":1670101520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00161-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1038\/s43018-020-00161-w","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"1 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}